Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07394218
What this trial is testing

CtDNA-guided Treatment Decision-making

Who this might be right for
Metastatic Breast Cancer ( HER2 Negative)ctDNA
Fudan University 122
Not applicableActive Not RecruitingNCT04246203
What this trial is testing

Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ludwig-Maximilians - University of Munich 200
Not applicableNot Yet RecruitingNCT07170046
What this trial is testing

Predictive Value of CEA and ctDNA in Lung Cancer Recurrence

Who this might be right for
Lung Carcinoma
Guangdong Provincial People's Hospital 100
Not applicableStudy completedNCT02410603
What this trial is testing

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Who this might be right for
Lung CancerLung NeoplasmsCancer of Lung+8 more
Mayo Clinic 64
Not applicableStudy completedNCT04400357
What this trial is testing

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CystsPancreatic Endocrine Tumors+4 more
Ruijin Hospital 268
Not applicableLooking for participantsNCT06693830
What this trial is testing

CtDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Who this might be right for
LymphomaLymphoma, B-CellDiffuse Large B Cell Lymphoma+2 more
Hua-Jay J Cherng, MD 40
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Testing effectiveness (Phase 2)Looking for participantsNCT06426511
What this trial is testing

CtDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06088381
What this trial is testing

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more
University of Maryland, Baltimore 61
Not applicableActive Not RecruitingNCT07407244
What this trial is testing

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

Who this might be right for
Breast Cancer
Institute of Oncology Ljubljana 268
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759492
What this trial is testing

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III Unresectable
Intergroupe Francophone de Cancerologie Thoracique 177
Not applicableStudy completedNCT03540563
What this trial is testing

CtDNA as a Biomarker for Treatment Response in HNSCC

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
The Netherlands Cancer Institute 70
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Not applicableActive Not RecruitingNCT05674422
What this trial is testing

GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.

Who this might be right for
Patients With Locally Advanced Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 120
Not applicableUnknownNCT03805256
What this trial is testing

Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer

Who this might be right for
Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cnacer
Second Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07012954
What this trial is testing

CtDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 64
Not applicableUnknownNCT04326751
What this trial is testing

Evolution of Multiple Primary Lung Cancer (Evolution)

Who this might be right for
Multiple Primary Lung CancersLung CancerNon Small Cell Lung Cancer
Peking University People's Hospital 20
Not applicableLooking for participantsNCT05433753
What this trial is testing

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

Who this might be right for
HER2-positive Breast Cancer
National Cancer Center, Japan 60
Not applicableUnknownNCT05641870
What this trial is testing

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Who this might be right for
Lung CancerStage III Lung CancerUnresectable Lung Carcinoma
Parc de Salut Mar 80
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Next Page